Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Questcor reports Acthar adverse effects data, NY Times says
Yahoo/Fly on the Wall
Friday, July 11, 2014 - 8:29am
tags:
adverse events, Questcor, Acthar
Dengue Vaccine Shows Promise Against 3 Out of 4 Viruses
Bloomberg
Friday, July 11, 2014 - 8:21am
tags:
dengue, vaccines, Sanofi
India's Sun Pharma recalls over 40,000 bottles of antidepressant
Yahoo/Reuters
Friday, July 11, 2014 - 8:20am
tags:
India, Sun Pharma, antidepressants, recalls
Great Deal! AbbVie Will Buy Shire and Investors Will Be Rewarded
TheStreet.com
Friday, July 11, 2014 - 8:18am
tags:
AbbVie, Shire, M&A
Astellas Seeks FDA Nod for Fungal Infection Treatment
Yahoo/Zacks.com
Thursday, July 10, 2014 - 5:50pm
tags:
Astellas, FDA, fungal infections, isavuconazole
Kythera announces FDA acceptance of ATX-101 NDA
Yahoo/Fly on the Wall
Thursday, July 10, 2014 - 5:43pm
tags:
FDA, ATX-101, Kythera, double chin
FDA Places Clinical Hold On Phase 3 Trial Of Novel Anticoagulant
Forbes
Thursday, July 10, 2014 - 3:42pm
tags:
FDA, Regado Biosciences, anticoagulants, Revolixys
Jounce Taps Merck Vet to Lead Cancer Drug Push
Motley Fool
Thursday, July 10, 2014 - 3:40pm
tags:
Jounce Therapeutics, Merck, cancer immunotherapy
Earnings Preview: Johnson & Johnson Q2 2014
Seeking Alpha
Thursday, July 10, 2014 - 3:24pm
tags:
earnings, JNJ
3 Pharma Stocks to Watch: Allergan, Valeant, and AbbVie
Motley Fool
Thursday, July 10, 2014 - 11:33am
tags:
M&A, Allergan, Valeant Pharmaceuticals, AbbVie, Shire
Novartis' Phase III Results on Secukinumab Published
Yahoo/Zacks.com
Thursday, July 10, 2014 - 11:30am
tags:
psoriasis, secukinumab, Novartis
A Pre-Earnings Update On Gilead
Seeking Alpha
Thursday, July 10, 2014 - 11:29am
tags:
Gilead Sciences, earnings
Vycor Medical: A Hidden Medical Device Gem
Seeking Alpha
Thursday, July 10, 2014 - 11:05am
tags:
Vycor Medical, devices
Are Cancer Vaccines Worth an Investment?
Motley Fool
Thursday, July 10, 2014 - 10:28am
tags:
vaccines, cancer, CTL019, Provenge, Dendreon, Novartis, Bristol-Myers Squibb
Bristol to seek melanoma approval for Opdivo ahead of expectations
Yahoo/Reuters
Thursday, July 10, 2014 - 10:20am
tags:
Bristol-Myers Squibb, melanoma, Opdivo
[video] Allergan CEO comes out swinging
CNBC
Thursday, July 10, 2014 - 9:04am
tags:
Allergan, Pharma CEOs, M&A, Valeant Pharmaceuticals, David Pyott
Ocera Therapeutics Inc raises $25.2 mln public offering
Reuters
Thursday, July 10, 2014 - 8:59am
tags:
Ocera Therapeutics, stock offering, OCR-002
Will Curis (CRIS) Crush Estimates at Its Next Earnings Report?
Yahoo/Zacks.com
Thursday, July 10, 2014 - 8:58am
tags:
earnings, Curis
Cytokinetics announces additional results relating to Tirasemtiv
The Fly on the Wall
Thursday, July 10, 2014 - 8:55am
tags:
Cytokinetics, Tirasemtiv, Lou Gehrig's disease, amyotrophic lateral sclerosis
Latest Sarepta Study Update Shows Greater Decline in Walking Ability
TheStreet.com
Thursday, July 10, 2014 - 8:51am
tags:
Sarepta Therapeutics, eteplirsen, Duchenne Muscular Dystrophy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.